/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.06%
Natural Gas
-3.02%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
EUR/USD
-0.06%
Natural Gas
-3.02%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Bitcoin ETFs: After Record $328M Outflows, What Happens Next?
about 3 hours ago
Vitalik Buterin Backs Ethereum PoS Transition amid Community Debates
about 4 hours ago
Crypto Market Outlook: BTC, SOL, ETH, DOGE Face Downward Pressure
about 5 hours ago
Crypto Market Recap: Ripple (XRP), SHIB and Binance Seize the Limelight
about 13 hours ago
The Week Ahead: US Jobs Report, the Fed, China Stats, and Yen Intervention Chatter
about 18 hours ago
Can Amazon and Apple Uphold the S&P 500’s Lofty Valuations?
1 day ago
PEPE Price Forecast: What Next after 65% Gains in 10-days
37 minutes ago
Dogecoin (DOGE) Price Forecast: What Next After Holding $0.15 Support?
about 4 hours ago
Optimism (OP) Price Prediction: Bulls Aiming for $4 Retest after 20% Gains
about 3 hours ago
Week Ahead: FOMC and Jobs Data in Sight
about 10 hours ago
USD/JPY Closing in on 1990 Highs
about 10 hours ago
EUR/USD: Bears to Remain in Control from $1.07?
about 10 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
INMB
profile
INmune Bio Inc
Follow
INMB
(
Nasdaq - US
)
N/A
11.25
+0.41 (+3.78%)
in
:
usd
•
As of: Apr 26, 2024 15:59
UTC -4
Open
11.06
High
11.68
Low
11.00
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
INmune Bio Inc
CEO
Raymond J. Tesi
Headquarters
225 ne mizner blvd., suite 640
boca raton, fl 33432, united states
Auditor
Marcum llp
Employees
17
Share Holders
26
Website
www.inmunebio.com
Industry
biotechnology
Sector
health technology
Company Overview
INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio Inc. is based in La Jolla, United States.
INmune Bio Inc
Statistics
Valuation Measures
Market Capitalization
2
204.75M
Enterprise Value
178.82M
Enterprise Value/EBITDA
(ttm)
-6.06
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
5.45
Price to Sales
(ttm)
1.33K
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
100.00%
Operating Margin
(ttm)
-19360.00%
Profit Margin
(ttm)
-20318.78%
Return on Equity
(ttm)
-64.11%
Return on Invested Capital
(ttm)
-63.17%
Return on Assets
(ttm)
-45.57%
Income Statement
Revenue
(ttm)
155.00K
Revenue Per Share
(ttm)
0.01
Gross Profit
(ttm)
155.00K
EBITDA
(ttm)
3
-29.52M
Net Income Avi to Common
(ttm)
-30.01M
Diluted EPS
(ttm)
-1.67
Share Statistics
Beta (5Y Monthly)
1.99
52-Week Change
55.17%
S&P500 52-Week Change
25.74%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
18.03M
Dividend Yield
0.00%
Float
4
11.63M
%
Held by Insiders
36.10%
%
Held by Institutions
12.72%
Balance Sheet
Total Cash
(mrq)
35.85M
Total Cash Per Share
(mrq)
1.99
Total Debt
(mrq)
9.92M
Total Debt/Equity
(mrq)
26.57%
Current Ratio
(mrq)
2.16%
Quick Ratio
(mrq)
2.16%
Book Value Per Share
(mrq)
2.08
Cash Flow
Operating Cash Flow Per Share
(ytd)
-0.67
Free Cash Flow
(ytd)
-11.98M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker